Biotech · Private company · North Liberty, IA, US
JMI Laboratories
Track this companyFree. Adds JMI Laboratories to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials1
- Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream InfectionPHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02651428 · fetched Nov 12, 2026
NIH awards6
- A30: BACTERIAL IN VITRO SCREENINGFiscal year 2026 · $65KNIH RePORTER 75N93019D00011-0-759302600001-1 · fetched Nov 12, 2026
- In Vitro Assessment of Antimicrobial Activity (IVAAA)Fiscal year 2026 · $2.5KNIH RePORTER 75N93026D00019-0-9999-1 · fetched Nov 12, 2026
- Task A27: Antibacterial MICs of a Gram-Negative Targeted Compound CollectionFiscal year 2024 · $342KNIH RePORTER 75N93019D00011-0-759302400001-1 · fetched Nov 12, 2026
- Task A28: In Vitro Screening for Antibacterial Activity Against Disease PathogensFiscal year 2024 · $70KNIH RePORTER 75N93019D00011-0-759302400002-1 · fetched Nov 12, 2026
- Task A23: Antibiotic-Resistant Neisseria Gonorrhoeae MIC DeterminationFiscal year 2024 · $39.6KNIH RePORTER 75N93019D00011-P00003-759302300003-1 · fetched Nov 12, 2026
- Task A24: In Vitro Screening for Antibacterial Activity Against Bacterial PathogensFiscal year 2024 · $26.5KNIH RePORTER 75N93019D00011-P00004-759302300002-1 · fetched Nov 12, 2026